bamlanivimab
adintrevimab
SARS-CoV-2
Wuhan pneumonia
novel coronavirus pneumonia
coronavirus disease 2019
Wuhan virus
2019-nCoV acute respiratory disease
COVID-19
corona
coronavirus
Wuhan flu
Wuhan coronavirus
deltacron
anticorrelate
Chinese virus
China virus
mapatumumab
patritumab
zanolimumab
guselkumab
immunocompatible
sonepcizumab
tucotuzumab
elotuzumab
panitumumab
naptumomab estafenatox
amlitelimab
dacetuzumab
properdin
conatumumab
oleclumab
cibisatamab
onartuzumab
antimonoclonal
antiantibody
Theta variant
muromonab
antipeptide
drozitumab
agonistic monoclonal antibody
bivatuzumab
seroblock
vobarilizumab
intetumumab
immunopeptide
radioimmunoreactivity
Zeta variant
ozogamicin
Lambda variant